Table 1.

Patient Characteristics, Response, and Toxicity

Radiation Treatment Intent	N (%)
Local control in patients with residual nodal disease after definitive surgical resection	13 (50%)
Local control in patients with unresectable chest wall or nodal recurrence after prior mastectomy	4 (15%)
Pre-operative	4 (15%)
Palliation	5 (19%)
Radiation Regimen
Maximum dose
50 Gy	5
60 Gy	2
≥66 Gy	19
Fractionation
Daily	25
Twice daily (BID)	1
TNBC
Yes	10 (38%)
No	16 (61%)
Response
PR/CR	19 (73%)
SD/PD	7 (27%)
CTO
n = 4	3 (75%)
Toxicity
G3 Toxicity - overall	14 (54%)
G3 toxicity - daily capecitabine (n=9)	7 (78%)
G3 toxicity - weekday only capecitabine (n=17)	7 (41%)
Grade IV/V toxicity	0 (0%)

^*> one grade three non-dermatitis toxicity, Gy, Gray; TNBC, triple negative breast cancer; PR/CR partial or complete response; SD/PD Stable or progressive disease; CTO convert to operable